BrightSpring Health Soars Post-IPO on Strong Earnings and Upbeat Analyst Targets

BrightSpring Health Services, Inc. (NASDAQ:BTSG) is one of the 11 Best Performing IPOs in the Last 2 Years.

The company sees its price target elevated by analysts following a positive second quarter and an upward change in revenue and adjusted EBITDA guidance.

BrightSpring Health Soars Post-IPO on Strong Earnings and Upbeat Analyst Targets

Monkey Business Images/Shutterstock.com

BrightSpring Health Services, Inc. announced a 29% year-over-year revenue growth, reaching $3.1 billion for Q2 2025. Its earnings call transcript, released on August 1, 2025, further indicated a growth in revenue in its Pharmacy Solutions by 32% year-over-year, with specialty scripts experiencing a 38% increase. Following such strong performance, the company elevated its 2025 revenue and adjusted EBITDA guidance, signaling a positive outlook.

Subsequently, many analysts have raised their price target on the stock. Deutsche Bank, for instance, raised the price target from $25 to $30 while Bank of America increased it from $27.50 to $31. The consensus rating on the stock remains a Buy.

BrightSpring Health Services, Inc. has shown significant growth since its IPO, with the % growth to date standing notably at 147.09%.

BrightSpring Health Services, Inc. is a leading healthcare company founded in 1974. Headquartered in Kentucky, the company specializes in providing home and community-based health and pharmacy services to people with complex health needs.

READ NEXT: 13 Best Freight Stocks to Invest in Now and 12 Jim Cramer Stock Picks this Week

Disclosure. None.